PPB Approves Drug to Manage Schizophrenia
The Pharmacy and Poisons Board (PPB) has approved the use of Paliperidone Palmitate, a drug manufactured by Janssen pharmaceutical companies of Johnson & Johnson, for the maintenance treatment of schizophrenia
Read on